Shivali Devjani, Ogechi Ezemma, Kristen J. Kelley, Maryanne M. Senna
We don't know much about this study yet.
We're maintaining the world's largest resposity of hair loss
research. You can help out the community by
sending a PDF of this study here
.
Not sure how to get a study's PDF? You can email the authors
of the study.
The review discusses traditional hair loss treatments like minoxidil and finasteride, and newer options like Low-Level Laser Therapy, microneedling, and platelet-richplasma for androgeneticalopecia. It highlights the need for more high-quality trials to assess these treatments' effectiveness and standardized protocols for emerging therapies.
The conversation discusses alternatives to Platelet-richplasma (PRP) for treating androgenicalopecia. Treatments mentioned include Minoxidil, finasteride, and RU58841.
In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.
Microneedling and Platelet-RichPlasma (PRP) are equally effective for treating androgeneticalopecia, with no additional benefits from PRP over microneedling. Both treatments are safe and well-tolerated.
Hair loss discussion includes treatments like Minoxidil, finasteride, and RU58841. Plateletrichplasma treatment is considered expensive but cheaper than hair transplant.